RGC32 antibody (AA 98-137)
Quick Overview for RGC32 antibody (AA 98-137) (ABIN1386922)
Target
See all RGC32 (C13orf15) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 98-137
-
Cross-Reactivity
- Human, Mouse, Rat
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human RGC32
-
Isotype
- IgG
-
-
-
-
Application Notes
-
WB 1:300-5000
IHC-P 1:200-400
IF(IHC-P) 1:50-200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Expiry Date
- 12 months
-
-
-
: "RGC-32 is expressed in the human atherosclerotic arterial wall: Role in C5b-9-induced cell proliferation and migration." in: Experimental and molecular pathology, Vol. 101, Issue 2, pp. 221-230, (2016) (PubMed).
-
: "RGC-32 is expressed in the human atherosclerotic arterial wall: Role in C5b-9-induced cell proliferation and migration." in: Experimental and molecular pathology, Vol. 101, Issue 2, pp. 221-230, (2016) (PubMed).
-
- RGC32 (C13orf15) (Chromosome 13 Open Reading Frame 15 (C13orf15))
-
Alternative Name
- RGC32
-
Background
-
Synonyms: RGC32, RGC-32, C13orf15, bA157L14.2, Regulator of cell cycle RGCC, Response gene to complement 32 protein, RGCC
Background: Modulates the activity of cell cycle-specific kinases. Enhances CDK1 activity. May contribute to the regulation of the cell cycle. May inhibit growth of glioma cells by promoting arrest of mitotic progression at the G2/M transition. Fibrogenic factor contributing to the pathogenesis of renal fibrosis through fibroblast activation.
-
Gene ID
- 28984
-
UniProt
- Q9H4X1
Target
-